In Summer 2000, IAVI's Scientific Advisory Committee (SAC) was reorganized so it can better guide the organization's research and development program, which has grown considerably since IAVI's founding in 1996. In addition to the main advisory committee, there are now three sub-committees overseeing specific areas: HIV vaccine science; international clinical trials and project management for IAVI's vaccine development partnerships. Each sub-committee is chaired by a SAC member and consists of 5-10 additional scientists, along with an executive secretary from IAVI's Research and Development staff.

The following is a complete list of SAC and sub-committee members.

SCIENTIFIC ADVISORY COMMITTEE \ Chair: Jaap Goudsmit, University of Amsterdam, Netherlands

Members:
Ian Gust, University of Melbourne, Australia
Philip Johnson, Children's Research Institute, Columbus, Ohio, USA
Norman Letvin, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
Edward K. Mbidde, Uganda Cancer Institute, Kampala, Uganda
Andrew McMichael, University of Oxford, UK
Neal Nathanson, University of Pennsylvania, Philadelphia, USA
Vulimiri Ramalingaswami, All India Institute of Medical Sciences, New Delhi, India
Helen Rees, Greater Johannesburg Metropolitan Reproductive Health Research, Johannesburg, South Africa
Jerald C. Sadoff, Merck Research Laboratories, West Point, Pennsylvania, USA
Mauro Schechter, Universidade Federal do Rio de Janero, Brazil
Hans Wigzell, Karolinska Institute, Stockholm, Sweden

INTERNATIONAL CLINICAL TRIALS \ Chair: Helen Rees \ Executive Secretary: Jane Rowley, IAVI

Members:
Don Burke, Johns Hopkins University, Baltimore, Maryland, USA
Edward Mbidde, Uganda Cancer Institute, Kampala, Uganda
Frank Plummer, University of Nairobi, Kenya
Mauro Schecter, Universidade Federal do Rio de Janero, Brazil
Haynes Sheppard, California Dept. of Health Services, Berkeley, California, USA
Sriram Prasad Tripathy, Pune, India
Hilton Whittle, MRC Laboratories, Banjul, Gambia
Janet Wittes, Statistics Collaborative, Washington, DC, USA

HIV VACCINE SCIENCE \ Chair: Jaap Goudsmit \ Executive Secretary: Vijay Mehra, IAVI

Members:
Rafi Ahmed, Emory University, Atlanta, USA
Frances Gotch, Chelsea & Westminster Hospital, London, UK
Carl Hanson, California Dept. of Health Services, Berkeley, USA
Shiu-Lok Hu, University of Washington, Seattle, USA
Jan Holmgren, G&oumlteborg University, G&oumlteborg, Sweden
Philip Johnson, Children's Research Institute, Columbus, Ohio, USA
Norman Letvin, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
Mike Levine, Johns Hopkins University, Baltimore, Maryland, USA
Neal Nathanson, University of Pennsylvania, Philadelphia, USA

PROJECT MANAGEMENT \ Chair: Ian Gust \ Executive Secretary: Chip Carnathan, IAVI

Members:
Marie-Paule Kieny, INSERM, Strasbourg, France
Jack Melling, IAVI consultant, Stroudsburg, Pennsylvania, USA
John Petricciani, IAVI consultant, Palm Springs, California, USA
Stanley Plotkin, University of Pennsylvania, Doylestown, USA
Jerald B. Sadoff, Merck Research Laboratories, West Point, Pennsylvania, USA

000910
IAVI2000-090111

©2000. The IAVI Report.

ÆGiS is made possible through unrestricted grants from Roxane Laboratories, Inc., iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1990, 2000. ÆGiS & the Sisters of Saint Elizabeth of Hungary. All materials appearing on ÆGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGiS and the Sisters of Saint. Elizabeth of Hungary, or the party credited as the provider of the content.